PHADEBACT MONOCLONAL GC TEST, MODIFICATION

Antiserum, Coagglutination (direct) Neisseria Gonorrhoeae

KARO BIO DIAGNOSTICS AB

The following data is part of a premarket notification filed by Karo Bio Diagnostics Ab with the FDA for Phadebact Monoclonal Gc Test, Modification.

Pre-market Notification Details

Device IDK921075
510k NumberK921075
Device Name:PHADEBACT MONOCLONAL GC TEST, MODIFICATION
ClassificationAntiserum, Coagglutination (direct) Neisseria Gonorrhoeae
Applicant KARO BIO DIAGNOSTICS AB LUNASTIGEN 3 S-141 44 Huddinge, Sweden,  SC
ContactBengt Gustavsson
CorrespondentBengt Gustavsson
KARO BIO DIAGNOSTICS AB LUNASTIGEN 3 S-141 44 Huddinge, Sweden,  SC
Product CodeLIC  
CFR Regulation Number866.3390 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1992-02-28
Decision Date1992-05-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.